Related by context. All words. (Click for frequent words.) 86 Zenvia ™ 77 pseudobulbar affect PBA 76 Zenvia TM 75 TELINTRA 75 PEGINTRON TM 75 evaluating satraplatin 74 Zorbtive TM 74 FOLFOX6 chemotherapy regimen 74 oral prodrug 73 SPRYCEL ® 73 sapropterin dihydrochloride 73 5 FU leucovorin 73 virus HCV protease inhibitor 73 refractory chronic lymphocytic 73 Meets Primary Endpoint 73 COLAZAL R 73 R Saizen R 73 trastuzumab Herceptin R 72 bevacizumab Avastin R 72 beta 1a 72 Neurodex 72 methylnaltrexone bromide 72 prokinetic agent 72 Besivance 72 evaluating tivozanib 72 interferon gamma 1b 72 diarrhea predominant irritable 72 dasatinib Sprycel ® 72 formerly LymphoStat B 72 Completes Patient Enrollment 72 cetuximab Erbitux R 72 arsenic trioxide injection 72 docetaxel Taxotere R 72 FDA APPROVES 72 TO AVOID PREGNANCY WHILE 72 Xeloda ® 72 MAGE A3 ASCI 72 Personalized Immunotherapy 71 lexidronam injection 71 vapreotide acetate 71 systemic anaplastic large 71 Submits NDA 71 NUEDEXTA ™ 71 Tezampanel 71 LymphoStat B TM 71 Phase 2b Clinical Trial 71 oxaliplatin Eloxatin 71 Xcytrin R 71 erlotinib Tarceva R 71 markets HP Acthar 71 CYT# potent vascular disrupting 71 Initiates Enrollment 71 Fludara ® 71 ALN HPN 71 docetaxel Taxotere ® 71 Clolar ® 71 Panzem R 71 Solazed TM 71 erlotinib Tarceva ® 71 Phase IIb Trial 71 R lenalidomide 71 elotuzumab 71 SinuNase ™ 71 octreotide acetate 71 novel histone deacetylase 71 Receives Orphan Drug Designation 71 XL# anticancer compounds 71 cell lymphoma CTCL 71 BCG refractory carcinoma 71 FOLOTYN ® 71 ALN PCS 71 ocular formulation 71 Initiates Phase II 71 R sorafenib tablets 70 developing Bicifadine serotonin 70 AAG geldanamycin analog 70 Copegus ® 70 FEMALES SHOULD BE ADVISED 70 RAPTIVA 70 post herpetic neuralgia PHN 70 Gemzar ® 70 Inhalation Aerosol 70 PNP inhibitor 70 ularitide 70 NDA Submission 70 Phase IIb Clinical Trial 70 Interferon beta 1a 70 SinuNase TM 70 Fibrillex TM 70 cisplatin gemcitabine 70 Durezol TM 70 octreotide implant 70 AVASTIN 70 HP Acthar Gel repository 70 IL# PE#QQR 70 novel emulsion formulation 70 ELADUR TM 70 Androxal TM 70 corticotropin injection 70 sitaxsentan 70 JAK inhibitor 70 lintuzumab SGN 70 PDX pralatrexate 70 Ovitrelle R Serostim 70 FUSILEV ® 70 transthyretin mediated amyloidosis ATTR 70 VISICOL R 70 phase III isavuconazole 70 Pivotal Phase III 70 Aryplase 70 rasagiline tablets 70 Phase 2b Trial 70 Serdaxin ® 70 DDP# 70 Gel repository corticotropin injection 70 pregabalin Lyrica 70 adenosine injection 70 Aflibercept 70 non nucleoside inhibitor 70 PEGylated anti 70 receiving INTRON 70 TRISENOX R 70 mGluR5 negative 70 orally administered inhibitor 70 mGluR5 NAM 69 INSPIRE Trial Phase III 69 2 methoxyestradiol 69 thalidomide Thalomid 69 FUSILEV enhances 69 Novel Oral 69 Neulasta R 69 catheter occlusion 69 ADP receptor antagonist 69 phase IIb clinical 69 MOVIPREP R 69 Crofelemer budesonide foam 69 hypoxia activated prodrug 69 abacavir sulfate lamivudine 69 Alpha interferons including 69 TRANSDUR ® 69 Soriatane 69 balsalazide disodium Capsules 69 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 69 ATRA IV 69 sorafenib tablets 69 PRT# 69 Panzem R NCD 69 alpha interferons 69 PEGylated interferon beta 1a 69 TRANSDUR ™ 69 oral beclomethasone dipropionate 69 metaglidasen 69 plus prednisone prednisolone 69 sunitinib Sutent ® 69 topically applied SEPA 69 TNF Tumor Necrosis Factor 69 familial amyloidotic polyneuropathy FAP 69 PDE4 inhibitor 69 Navelbine ® 69 KRN# 69 ELADUR ™ 69 Ecallantide 69 Peginterferon alfa 2a 69 allosteric modulator NAM 69 investigational monoclonal antibody 69 SUPPRELIN R LA 69 ® lenalidomide 69 AVONEX ® 69 Copegus ribavirin 69 Pegloticase 69 CCX# B 69 sorafenib Nexavar 69 peripherally acting 69 RELOVAIR ™ 69 mGluR2 positive 69 R bendamustine hydrochloride 69 Oracea TM 69 generation purine nucleoside 69 Vaprisol 69 acetonide FA 69 LymphoStat B belimumab 69 MyVax R 69 6R BH4 69 ® bortezomib 69 Hsp# Inhibitor 69 Initiates Phase III 69 investigational humanized monoclonal antibody 69 delivers fluocinolone acetonide FA 69 topical gel formulation 69 Pegasys ® 69 Files Investigational 69 dihydrochloride Tablets 69 class anticancer quinolone 69 VIVITROL ® 69 Kuvan TM sapropterin 69 Cellegesic 69 Aloxi ® 69 alvespimycin 69 SILENOR 69 Albuferon TM 69 confirmatory Phase III 69 Aloxi injection 69 Factor VIIa 69 Luteinizing Hormone Releasing Hormone 69 TLK# 69 Peginterferon alfa 2b 69 Bicifadine 69 armodafinil Tablets C 69 Serostim R 69 candidates Azedra TM 69 AzaSite Plus 69 liposomal formulation 69 Sensipar ® 68 PEGylated Fab fragment 68 PENTASA 68 GW# [003] 68 COPEGUS R 68 Multiple Ascending Dose 68 alfa 2a 68 AzaSite TM 68 vinorelbine tartrate 68 Epratuzumab 68 Evoltra ® 68 Entereg R 68 LEP ETU 68 HCV protease inhibitor 68 Rebif ® 68 PF # [002] 68 Intravenous Human 68 neutropenia thrombocytopenia 68 somatostatin analog 68 gastrointestinal disorders ATI 68 Initiates Clinical Trial 68 Initiated Phase 68 Pruvel 68 lenalidomide dexamethasone 68 personalized cellular immunotherapy 68 ARCALYST R 68 pan HDAC inhibitor 68 Pivotal Phase 68 KNS # 68 Solazed ™ 68 PRN FDA Approves 68 bevacizumab Avastin ® 68 INCB# [001] 68 Phase 2a Clinical Trial 68 alemtuzumab MS 68 Oracea R 68 Granted Orphan Drug 68 cardiometabolic diseases Glucophage 68 Presents Preclinical Data 68 Investigational Oral 68 hydrochloride tablets 68 Begins Dosing 68 Saforis 68 HGS ETR1 mapatumumab 68 Serostim ® 68 Elagolix 68 FACTIVE R gemifloxacin 68 sevelamer carbonate 68 Targretin capsules 68 nucleoside analog 68 relapsed refractory multiple myeloma 68 novel orally inhaled 68 investigational pharmacologically unique 68 cyclophosphamide methotrexate 68 ISTODAX ® 68 Leukine ® 68 RECOTHROM R 68 Alocrest 68 Iloperidone 68 Pafuramidine 68 Archexin 68 polyneuropathy HIV DSP 68 paclitaxel Taxol ® 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 potent CYP#A# inhibitors 68 Announces Tentative Approval 68 oral nucleoside analogue 68 Orally administered 68 histone deacetylase HDAC inhibitor 68 Aztreonam lysine 68 Inhalation Solution 68 Phase 2a Trial 68 oral ridaforolimus 68 nalbuphine ER 68 First Patient Dosed 68 ONCASPAR 68 mapatumumab 68 severe hypercholesterolemia 68 diabetic neuropathic pain 68 REVLIMID R 68 dyskinesia PD LID 68 ZOLINZA 68 sunitinib malate 68 ARIKACE ™ 68 pralatrexate injection folate analogue 68 Romiplostim 68 headache nasopharyngitis 68 huC# DM4 68 PEGASYS ® 68 Telik logo TELINTRA 68 XP# XP# 68 receptor tyrosine kinase inhibitor 68 FDA Accepts 68 Xibrom TM 68 Spiegelmer ® 68 INVANZ 68 Vitrasert R 68 Targretin 68 Demonstrates Significant 68 RAPAMUNE 68 Initiate Clinical Trial 68 metastatic castration resistant 68 Patients Treated With 68 baminercept 68 Diovan Exforge Tekturna Zelnorm 68 AeroLEF TM 68 CRMD# 68 Ridaforolimus 68 forodesine 68 IV Busulfex 68 Dyloject TM 68 HuLuc# 68 liposome injection 68 TAFA# 68 unique alkylating agent 68 incyclinide 68 ® decitabine 68 Release Tablets 68 Dementia Related Psychosis 68 BRILINTA 68 candesartan cilexetil 68 Investigational Treatment 68 plus DOXIL 68 oropharyngeal candidiasis OPC 68 cetuximab Erbitux ® 68 POSIDUR TM ELADUR TM 68 Phase #b/#a clinical 68 JAK2 Inhibitor 68 cutaneous T 68 ACTEMRA TM 68 R metformin Concor 68 IN PATIENTS WITH 68 TELCYTA 68 Liprotamase 68 5 HT3 antagonist 68 PEG SN# 68 induced macular edema 68 Vidaza R 68 PROVENGE ® 67 Initiates Clinical 67 Tiuxetan 67 PHARMACEUTICALS INC 67 Ostarine ™ 67 E1 INT TM 67 Initiate Phase 67 neutropenia dehydration dyspnea 67 herpetic keratitis 67 By JENNIFER LEARN 67 PI3K/Akt pathway inhibitor 67 cinacalcet HCl 67 intravesical infusion therapy 67 primary hypercholesterolemia 67 TKB# 67 palonosetron hydrochloride injection 67 metastatic hormone refractory 67 Files IND 67 Lenocta TM 67 Romidepsin 67 Eraxis 67 Adagen ® 67 norepinephrine reuptake inhibitor 67 sodium thiosulfate STS 67 ABILIFY R 67 Silodosin 67 Glufosfamide 67 REBETOL combination therapy 67 Squalamine 67 oral picoplatin 67 candidate Zenvia 67 DexaSite 67 Thalomid ® 67 metabolic disorders Saizen R 67 GATTEX TM 67 II Clinical Trial 67 fosbretabulin 67 opioid induced bowel dysfunction 67 brand ciclesonide HFA 67 Dalbavancin 67 etanercept Enbrel 67 panitumumab Vectibix R 67 tezampanel 67 rilonacept 67 oxymorphone ER 67 THALOMID 67 memantine HCl 67 metastatic malignant 67 Vicriviroc 67 sorafenib Nexavar R 67 ALVESCO ® 67 tizanidine hydrochloride short 67 Actimmune R 67 abatacept Orencia 67 hyperplasia BPH 67 CORT # 67 PROCTOCORT R 67 Ixempra 67 Parkinson disease levodopa induced 67 pan histone deacetylase 67 HCl Tablets 67 CIMZIA TM certolizumab pegol 67 ZEVALIN ® 67 Paraplatin ® 67 acyclovir Lauriad R 67 MEND CABG II 67 Randomized Double blind 67 Receives Approvable Letter 67 inhalation aerosol 67 ABILIFY ® 67 Aurexis R 67 pioglitazone HCl 67 alpha 2b 67 Nexavar ® 67 ™ pralatrexate injection 67 Pimavanserin 67 novel VDA molecule 67 infusional 5-FU/LV 67 rhIGF-I/rhIGFBP-3 67 Orphan Drug designations 67 IMiDs ® 67 GOUT 67 interferon beta 1a infertility 67 Kepivance 67 EXPAREL TM 67 ARCALYST ® 67 Friedreich Ataxia FRDA 67 Mylan Receives Approval 67 Somatuline Depot 67 molecular imaging radiopharmaceutical 67 Study Evaluating 67 subcutaneous formulation 67 plasma kallikrein inhibitor 67 Demonstrates Positive 67 Bosutinib 67 TRISENOX ® 67 Copegus R 67 EDEMA3 trial 67 visilizumab 67 MoxDuo IR 67 Toremifene 67 antibody MAb 67 Icatibant 67 Mg Uk 67 albiglutide 67 monoclonal antibody IgG1 Mab 67 Navelbine R 67 Luveris R Ovidrel R 67 Phase III confirmatory 67 myelofibrosis polycythemia vera 67 Agonist MABA program 67 IMiD 67 RhuDex ® 67 Achieves Primary Endpoint 67 Ziprasidone 67 bortezomib Velcade R 67 Pruvel ™ 67 Annamycin 67 MKC# MT 67 histamine dihydrochloride 67 Rapaflo 67 OMNARIS HFA 67 bowel syndrome IBS 67 LEVAQUIN ® 67 phase IIb trial 67 Kuvan R 67 GSK# [001] 67 Cerebril TM 67 FULL PRESCRIBING INFORMATION 67 targeted radiotherapeutic 67 SUTENT ® 67 volociximab 67 Zemiva TM 67 Cleviprex TM clevidipine 67 painful diabetic neuropathy 67 METOZOLV TM ODT metoclopramide 67 risedronate sodium tablets 67 Trial Evaluating 67 occlusion PAO 67 Tarceva TM 67 dependent kinase inhibitor 67 reslizumab 67 treat chronic sinusitis 67 Temsirolimus 67 Proxinium TM 67 plus prednisone 67 Iluvien ® 67 mitoxantrone plus 67 HDAC Inhibitor 67 Immunotherapeutic 67 markets COLAZAL 67 delivery polymer matrix 67 Completes Enrollment 67 lenalidomide Revlimid R 67 targeted antifolate 67 SPL# Gel vaginal microbicide 67 INTEGRILIN ® 67 Onalta ™ 67 vaginal candidiasis 67 candidate XP# 67 product platforms AZX# 67 Camptosar ® 67 Phase III Clinical Trial 67 XOPENEX HFA 67 brivaracetam 67 oncolytic virus therapies 67 ribavirin RBV 67 Femring ® 67 Onco TCS 67 dasatinib Sprycel 67 gemcitabine Gemzar ® 67 Exelixis compounds 67 HGS ETR2 67 JZP 67 BUPHENYL 67 Demonstrates Sustained 67 Bepreve TM 67 DAVANAT 67 Single Dose 67 YONDELIS 67 Zenvia Phase III 67 Oracea ® 67 N acetylgalactosamine 6 67 Cardium Therapeutics TM 67 Benazepril 67 Aloxi R 67 Phase 1b trial 67 RhuDex TM 67 Ereska 67 PLK1 SNALP 67 individualized cellular immunotherapy 67 Mg Usa 67 HCD# [002] 67 RELISTOR ® 67 somatropin Kuvan R 67 phase IIa clinical 67 Omacetaxine 67 cromolyn sodium 67 PREOS R 67 ALVESCO R 66 Febuxostat 66 modafinil Tablets C 66 PKC# 66 Ceflatonin R 66 esomeprazole Nexium 66 paclitaxel Taxol R 66 TRANSFORMS 66 IgG1 monoclonal antibody 66 adalimumab Humira 66 R#/MEM # 66 pediatric Crohn disease 66 XL# XL# 66 adriamycin 66 Soliris TM eculizumab 66 DOXIL 66 PHX# 66 temsirolimus Torisel 66 Disease IBD 66 Orapred ODT 66 modified glutathione analog 66 TYZEKA 66 ergot derivatives 66 Silenor ® 66 refractory gout 66 hydroxymethyl coenzyme 66 Vidaza ® 66 motexafin gadolinium Injection 66 valtorcitabine 66 TRX1 66 panitumumab Vectibix 66 CRTX 66 EVIZON ™ 66 PrevOnco 66 NU# direct 66 BYETTA ® 66 Lubiprostone 66 losartan potassium 66 highly selective inhibitor 66 investigational antiplatelet agent 66 Ozarelix 66 combines bupropion 66 IMiDs R 66 Bezielle 66 DIFICID ™ 66 Simulect 66 Phase III Trial 66 lumiliximab 66 Cetrorelix 66 GLP1 INT TM 66 evaluating Actimmune 66 cyclophosphamide doxorubicin vincristine 66 refractory AML 66 Refractory Hodgkin Lymphoma 66 intranasal formulation 66 EPIVIR 66 AEGR 66 Eloxatin ® 66 long acting muscarinic 66 Ventavis 66 initiated Phase Ib 66 AIR CF1 66 LibiGel ® 66 Zemplar Capsules 66 torsemide ER 66 KRYSTEXXA TM pegloticase 66 Eszopiclone 66 toenail onychomycosis 66 INFeD R 66 Lexiscan ® 66 pharmacokinetic PK study 66 cancer neuroendocrine tumor 66 Frozen Shoulder syndrome Adhesive 66 THALOMID R 66 ACTIQ ® 66 CD# CEA 66 apoptosis inducer 66 celgosivir 66 Methylnaltrexone 66 ® bendamustine hydrochloride 66 NUVIGIL ® 66 idiopathic thrombocytopenic purpura ITP 66 HIV distal sensory 66 Acute Attacks 66 Ocrelizumab 66 ceftazidime 66 oral deforolimus 66 ONTAK 66 Phase IIIb clinical 66 selective androgen receptor modulator 66 ACAPODENE R 66 Plecanatide 66 Diabetic Macular Edema 66 RANK Ligand inhibitor 66 morphine sulfate extended 66 R bisoprolol Euthyrox 66 Pegasys R 66 Quinamed 66 sitagliptin metformin 66 evaluating carfilzomib 66 esophageal candidiasis 66 peripheral sensory neuropathy 66 Phase Ib clinical trials 66 NS5B polymerase 66 Ovidrel 66 benign prostatic hypertrophy BPH 66 Solzira ™ 66 Amgen Neulasta R 66 TRAIL receptor antibodies 66 R bortezomib 66 BUPHENYL R 66 Fast Track Status 66 Difimicin 66 interferon alfacon 1 66 CIP TRAMADOL ER 66 MetroGel 66 inflammatory autoimmune diseases 66 hypertrichosis occurred 66 Amplimexon 66 human C1 inhibitor 66 Proquin XR 66 hyperphenylalaninemia HPA due 66 Lenocta 66 EOquin 66 Sanctura XR 66 Presents Preclinical 66 EFFEXOR XR 66 highly purified pasteurized 66 Trofex TM 66 OMNARIS Nasal Spray 66 Cimzia TM 66 selective estrogen receptor modulator 66 MKC# MKC# PP 66 MKC# 66 EDEMA3 66 markets Gelclair R 66 novel synthetic PEGylated 66 ITAX 66 Decitabine 66 relapsing multiple sclerosis 66 OMNARIS 66 ELADUR 66 STEDESA 66 diarrhea vomiting rash 66 Cloretazine ® 66 ENMD # 66 Traficet EN 66 Zemiva ™ 66 IMiDs ® compound 66 Platinol ® 66 5 lipoxygenase inhibitor 66 trastuzumab DM1 T DM1 66 Initiates Clinical Trials 66 UPLYSO 66 P#X# antagonist 66 Bazedoxifene 66 bicifadine 66 Testosterone MDTS ® 66 Amigal TM 66 Azedra TM 66 pomalidomide 66 Navelbine 66 Safinamide 66 Sodium oxybate 66 allosteric modulator PAM 66 Phase 1b clinical trials 66 coronary stent merged 66 Vilazodone 66 Recombinant Human 66 AZASITE 66 metformin sulfonylurea 66 gemcitabine cisplatin 66 HMG CoA reductase inhibitors 66 S1P antibody 66 Numoisyn Liquid 66 developing ACAPODENE 66 R roscovitine CDK cyclin 66 AzaSite Xtra 66 Xanafide 66 mitogen activated ERK kinase 66 Phase Ib clinical 66 #HT# 66 Xyrem ® 66 Shows Statistically Significant 66 acute bipolar mania 66 Ophena TM 66 non constipation irritable 66 FASLODEX 66 Danazol 66 Feraheme ® 66 developing ostarine selective 66 ferumoxytol Injection 66 Actimmune ® 66 evaluating Xcytrin 66 mertansine 66 Myelodysplastic Syndrome MDS 66 refractory cutaneous T 66 Adenoscan R 66 CHEAP ONLINE PHARMACY LOW 66 Drug Candidate 66 recurrent glioblastoma multiforme 66 alpha 2a 66 GATTEX ™ 66 triciribine phosphate monohydrate 66 tazobactam 66 Pemetrexed 66 IMA# 66 CANCIDAS 66 candidate SILENOR TM 66 ERBITUX cetuximab 66 novel topoisomerase 66 acute peripheral arterial 66 LENALIDOMIDE 66 Granulocyte Colony Stimulating Factor 66 Initiates Phase 2b 66 Mycophenolate Mofetil 66 % uracil topical 66 Solution XOPENEX HFA 66 ® chorionic gonadotropin 66 Aztreonam Lysine 66 HSP# inhibitor 66 dacarbazine DTIC 66 cannabinor 66 posaconazole 66 Vfend 66 Ropinirole 66 denileukin diftitox 66 TRIOLEX HE# APOPTONE HE# 66 treats paroxysmal nocturnal 66 imatinib Gleevec ® 66 dopamine receptor agonist 66 Ambrisentan 66 chronic eosinophilic leukemia 66 hoFH 66 dacetuzumab SGN 66 ODT metoclopramide HCl PEPCID 66 pharmacodynamic profiles 66 Elotuzumab 66 Amrubicin 66 SYCREST 66 fludarabine phosphate 66 sargramostim 66 dimebon latrepirdine 66 class mGluR5 inhibitor 66 AMRIX 66 sarcoma melanoma 66 Ranolazine 66 Chemophase 66 REPRONEX ® menotropins 66 Talabostat 66 Arcalyst 66 emtricitabine tenofovir 66 Novacort TM 66 Matrix Phase 2b 66 plus Copegus R 66 HuMax EGFr 66 investigational immunotherapy 66 Receives Orphan Drug 65 MNTX 65 IV APAP 65 CB2 selective receptor agonist 65 Pruvel TM 65 STELARA TM 65 Regeneron Pharma 65 omacetaxine mepesuccinate 65 myelodysplastic myeloproliferative diseases 65 Soliris eculizumab 65 Cloretazine 65 Submits Biologics License Application 65 Pegasys peginterferon alfa 2a 65 Anturol 65 TKM ApoB 65 Voreloxin 65 FDA Approvable Letter 65 Solzira TM 65 PROSTASCINT R 65 FOR FURTHER INFORMATION ABOUT 65 Brentuximab Vedotin SGN 65 NeuroSTAT ® 65 overactive bladder AA# 65 Levetiracetam 65 Vidaza azacitidine 65 XL# XL# XL# 65 Milestone Payments 65 LEVAQUIN 65 ACAPODENE 65 alvimopan 65 QUADRAMET R 65 Oral NKTR 65 CORLUX CORT # 65 Phase 1a clinical 65 Glatiramer Acetate 65 pegylated liposomal doxorubicin 65 Randomized Phase 65 pegylated interferons 65 Novolimus 65 mocetinostat MGCD# 65 tumor activated prodrug 65 Drug Eluting Stent System 65 TRANSDUR Sufentanil 65 MERREM IV 65 generation Hsp# inhibitor 65 telomerase therapeutic 65 Presents Positive 65 RITUXAN 65 evaluating picoplatin 65 TELINTRA R 65 cyclobenzaprine hydrochloride extended 65 ATPace TM 65 ABLYNX 65 non nucleoside HCV 65 Testosterone MDTS R 65 orally disintegrating formulation 65 Hyphanox 65 PRIALT 65 budesonide foam 65 BENICAR HCT 65 evaluating REVLIMID 65 rHuPH# recombinant human 65 mu opioid receptor antagonist 65 pegylated interferon alfa 2a 65 Visudyne R 65 R#/MEM 65 therapeutically inactive prodrug 65 ULTRASE 65 leukemia AML 65 telaprevir dosed 65 VAPRISOL 65 Frova ® 65 Xenazine ® 65 pentadentate logo R 65 Hydrochlorothiazide Tablets 65 Receives Fast Track 65 inflammatory PDE 65 essential thrombocythemia ET 65 Oxytrol R 65 XAGRID 65 treat male hypogonadism 65 zonisamide SR 65 itraconazole Sporanox 65 Pivotal Study 65 Zevalin R Ibritumomab 65 JAK1 65 Tolvaptan 65 TM Aganocide 65 Oral Fingolimod 65 AVAPRO 65 Antitumor Activity 65 Kinase Inhibitor 65 Vitrasert ® 65 humanized interleukin 6 65 xanthine oxidase inhibitor 65 polymerase inhibitor 65 5 Fluorouracil 65 proteasome inhibitor 65 Panzem ® 65 Gonal f R 65 lead molecular radiotherapeutic 65 Seliciclib 65 SinuNase 65 mesylate tablets 65 metformin HCl 65 IBS C 65 aripiprazole Abilify 65 samarium Sm 65 PANVAC VF 65 nilotinib Tasigna ® 65 tiapamil 65 HCV RNA polymerase 65 serotonin norepinephrine reuptake inhibitor 65 orally inhaled migraine 65 Ketotransdel TM 65 adecatumumab MT# 65 COPEGUS 65 Unit Dose Budesonide 65 depressive episodes associated 65 Diabetic Macular Edema DME 65 2A receptor agonist 65 Receives Milestone Payment 65 Plicera 65 demonstrated antitumor activity 65 AN# topical anti 65 ketolide antibiotic 65 Aldara ® 65 PHASE III 65 Dapagliflozin 65 Teva Provides Update 65 Rhucin ® recombinant 65 Troxatyl 65 gemcitabine Gemzar 65 olanzapine Zyprexa 65 temsirolimus Torisel ® 65 PEG INTRON 65 Azilect ® 65 Adjunctive Therapy 65 rabeprazole 65 Kuvan sapropterin dihydrochloride 65 MEND CABG 65 Pfizer Camptosar 65 TRANSDUR Bupivacaine 65 Expanded Indication 65 Nasdaq EPCT 65 Loceryl ® 65 Anturol ® 65 systemic RNAi therapeutic 65 teduglutide 65 Dual Opioid 65 targeting Inflammatory Bowel 65 aplindore 65 DUROS 65 Increlex R 65 Myelofibrosis 65 BENLYSTA TM 65 candidate deforolimus 65 dihydrochloride 65 icatibant 65 Sphingomab TM 65 NS#/#A protease 65 PRICE GREAT DISCOUNT FREE 65 miconazole Lauriad ® 65 Fludara 65 Complicated Skin 65 events thrombocytopenia neutropenia 65 treat benign prostatic 65 Panzem NCD 65 Busulfex 65 Milnacipran 65 parecoxib 65 Nasdaq VNDA 65 Cutaneous T 65 Zoloft sertraline 65 Fc fusion protein 65 inhibitor PPI 65 ritonavir boosted 65 CYP#A# CYP#D# 65 valopicitabine 65 Launches Generic Version 65 ELOXATIN 65 Namenda ® 65 PEG IFN 65 Efficacy Results 65 agonistic human 65 Catena ® 65 including eniluracil ADH 65 VICTOR E3 65 First Patient Enrolled 65 Aeolus Pharmaceuticals Announces 65 glatiramer 65 product Fentanyl TAIFUN 65 Marqibo TM